On Feb. 1, the official X account of The Drug Enforcement Administration (DEA) posted a photo of former President Richard Nixon and a caption meant to celebrate the legacy of the War on Drugs, but the comment section didn’t go as planned. Making things worse, the DEA posted it on the first day of Black History Month, which is especially ironic given that cannabis laws were … [Read more...] about DEA Celebrates War on Drugs in Cringey Post During Black History Month
DEA
DEA Re-Hires Agent Who Was Fired for Taking CBD
The Department of Justice has rescinded a DEA decision to fire a special agent who was let go due to a positive reading for CBD on a drug test. DEA special agent Anthony L. Armour will be re-hired as a special agent and be reimbursed for back pay and legal expenses after a years-long court battle that stretches back to 2019 when a routine drug test showed he had been using CBD, … [Read more...] about DEA Re-Hires Agent Who Was Fired for Taking CBD
DEA Considers Rescheduling Cannabis—What This Means For U.S. And Global Reform
Just weeks into 2024 we’ve already seen the Drug Enforcement Administration confirm it is reviewing the classification of cannabis under the Controlled Substances Act, along with the first public acknowledgement of its medical use by the Department of Health and Human Services. Amid an ‘unprecedented’ situation, speculation is rife around whether the U.S. is finally heading … [Read more...] about DEA Considers Rescheduling Cannabis—What This Means For U.S. And Global Reform
US federal health officials acknowledge ‘accepted medical use’ of cannabis
The DEA told congress it has the 'final authority' on any decision. Federal health officials in the US have acknowledged the ‘accepted medical use’ of cannabis for the first time, in documents confirming a recommendation that it be reclassified as a lower risk drug. The US Department of Health and Human Services (HHS) has released documents which confirm its recommendation that … [Read more...] about US federal health officials acknowledge ‘accepted medical use’ of cannabis
Drug Enforcement Administration Signals Intent to Reschedule Marijuana
On Dec. 19, 2023, Michael Miller, acting chief of the Drug Enforcement Administration (DEA) Office of Congressional Affairs, penned a letter to Congress advising that DEA is currently reviewing the Department of Health and Human Services’ (HHS) recommendations regarding rescheduling marijuana. Miller declared that “DEA has the final authority to schedule, reschedule, or … [Read more...] about Drug Enforcement Administration Signals Intent to Reschedule Marijuana
Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’
While some have speculated that the U.S. Drug Enforcement Administration (DEA) is on the cusp of deciding whether to accept or reject the Department of Health and Human Services (HHS) recommendation to reschedule cannabis under the Controlled Substances Act (CSA), Shane Pennington, partner at Porter Wright Morris & Arthur LLP, has a different perspective. He believes it … [Read more...] about Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’
US Congressman Urges DEA to Expedite Rescheduling Cannabis
Another U.S. congressman is putting pressure on the Drug Enforcement Administration (DEA) to follow through on a presidential request regarding cannabis reform. Rep. Steve Cohen, D-Tenn., wrote a letter Jan. 4 to DEA Administrator Anne Milgram urging her “in the strongest possible way” to act expeditiously on the Aug. 29 Department of Health and Human Services … [Read more...] about US Congressman Urges DEA to Expedite Rescheduling Cannabis
DEA Notice Shows Increase in Research Amounts for THC, Psilocybin, DMT, and More
The Drug Enforcement Agency (DEA) posted a notice on the Federal Register on Jan. 3, which includes the most recent breakdown of Schedule I Substances in its 2024 aggregate production quotas (APQ), as well as a wide variety of public comments and DEA responses. According to a Federal Register article published in November 2023, delta-9 THC (referred to as “d-9-THC” on the list) … [Read more...] about DEA Notice Shows Increase in Research Amounts for THC, Psilocybin, DMT, and More
Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation
The Dec. 13 letter, addressed to U.S. Attorney General Merrick Garland and Drug Enforcement Administration (DEA) Administrator Anne Milgram and signed by 29 former attorneys, comes in response to the U.S. Health and Human Services’ (HHS) August recommendation that cannabis be reclassified under the Controlled Substances Act (CSA). HHS still has not confirmed publicly the … [Read more...] about Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation
DEA warns Georgia to cancel plans to become first state to allow pharmacies to sell medical marijuana
The U.S. Drug Enforcement Administration is warning Georgia not to move forward with its plan to become the first state to allow pharmacies to distribute medical marijuana. DEA officials told pharmacies that dispensing medical marijuana would violate federal law. The Georgia Access to Medical Cannabis Commission, which oversees the state's medical marijuana industry, said it … [Read more...] about DEA warns Georgia to cancel plans to become first state to allow pharmacies to sell medical marijuana
